Endocrinology / diabetes clinical trials recruiting in Illinois

256 recruiting endocrinology / diabetes trials match in Illinois. Showing 20.

• A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerRecruiting

  Phase 3 · Hoffmann-La Roche · O'Fallon, Illinois

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Chicago, Illinois

• Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Recruiting

  Phase 2 · Sparrow Pharmaceuticals · Chicago, Illinois

• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusRecruiting

  Phase 3 · AstraZeneca · St Leonards

• Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine TumorsRecruiting

  Phase 1 · University of Chicago · Chicago, Illinois

• Stable Isotopes- Adults With ObesityRecruiting

  N/A · University of Illinois at Urbana-Champaign · Urbana, Illinois

• Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM MetricsRecruiting

  N/A · Milton S. Hershey Medical Center · Chicago, Illinois

• Role of Adiposomes in Endothelial DysfunctionRecruiting

  N/A · University of Illinois at Chicago · Chicago, Illinois

• Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerRecruiting

  N/A · Natera, Inc. · Greenbrae, California

• Empagliflozin Treatment in Kidney Transplant RecipientsRecruiting

  Phase 4 · VA Office of Research and Development · Hines, Illinois

• Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Recruiting

  Phase 3 · NRG Oncology · Alton, Illinois

• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsRecruiting

  Phase 1 · IDEAYA Biosciences · Zion, Illinois

• Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic FistulaRecruiting

  Phase 3 · SWOG Cancer Research Network · Chicago, Illinois

• Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 SystemRecruiting

  N/A · Insulet Corporation · Chicago, Illinois

• Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic CancerRecruiting

  Phase 1 / Phase 2 · National Cancer Institute (NCI) · Duarte, California

• Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanRecruiting

  Phase 1 · AbbVie · Chicago, Illinois

• PRImary Care Strategies for Weight Management (PRISM) StudyRecruiting

  N/A · Rush University Medical Center · Chicago, Illinois

• Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerRecruiting

  Phase 3 · AstraZeneca · Arlington Heights, Illinois

• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsRecruiting

  Phase 1 / Phase 2 · Artios Pharma Ltd · Hinsdale, Illinois

• Vitamin D for Prostate Endocrine TherapyRecruiting

  Phase 3 · University of Rochester · Danville, Illinois

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.